Mednax, Inc. (MD) News

Mednax, Inc. (MD): $24.70

0.36 (+1.48%)

POWR Rating

Component Grades













Filter MD News Items

MD News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

MD News Highlights

  • For MD, its 30 day story count is now at 4.
  • Over the past 20 days, the trend for MD's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
  • The most mentioned tickers in articles about MD are HCA and STAR.

Latest MD News From Around the Web

Below are the latest news stories about Mednax Inc that investors may wish to consider to help them evaluate MD as an investment opportunity.

Mednax (MD) Receives a Hold from Mizuho Securities

In a report issued on January 14, Ann Hynes from Mizuho Securities maintained a Hold rating on Mednax (MD – Research Report), with a price target of $28.00. The company's shares closed last Tuesday at $25.91. According to, Hynes is a 5-star analyst with an average return of 12.0% and a 65.5% success rate. Hynes covers the Healthcare sector, focusing on stocks such as Molina Healthcare, Quest Diagnostics, and Acadia Healthcare. Mednax has an analyst consensus of Hold, with a price target consensus of $29.50.

Catie Powers on TipRanks | January 19, 2022

Here's Why Seasoned Investors are Retaining Mednax (MD)

Banking on its strategic measures and a streamlined business, Mednax (MD) holds potential to reap benefits for investors.

Yahoo | January 12, 2022

Shareholders in MEDNAX (NYSE:MD) are in the red if they invested five years ago

MEDNAX, Inc. ( NYSE:MD ) shareholders should be happy to see the share price up 11% in the last month. But that is...

Yahoo | December 30, 2021

The Zacks Analyst Blog Highlights: Community Health Systems, Mednax, HCA Healthcare and Tenet Healthcare

The Zacks Analyst Blog Highlights: Community Health Systems, Mednax, HCA Healthcare and Tenet Healthcare

Yahoo | December 30, 2021

MEDNAX, Inc. (NYSE:MD) Forecasted to Earn Q1 2022 Earnings of $0.20 Per Share

MEDNAX, Inc. (NYSE:MD) Jefferies Financial Group issued their Q1 2022 earnings estimates for MEDNAX in a research note issued on Tuesday, December 21st. Jefferies Financial Group analyst B. Tanquilut anticipates that the company will post earnings per share of $0.20 for the quarter. Jefferies Financial Group also issued estimates for MEDNAXs Q2 2022 earnings []

Dakota Financial News | December 24, 2021

MEDNAX (NYSE:MD) Given New $32.00 Price Target at Credit Suisse Group

MEDNAX (NYSE:MD) had its target price decreased by Credit Suisse Group from $33.00 to $32.00 in a report released on Wednesday morning, Stock Target Advisor reports. Credit Suisse Group currently has an outperform rating on the stock. MD has been the topic of several other reports. BMO Capital Markets dropped their target price on MEDNAX []

Dakota Financial News | December 23, 2021

Here is What Hedge Funds Think About Mednax Inc. (MD)

Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market reached another high in recent weeks. On the other hand, technology hedge funds weren’t timid and registered double digit market beating gains. Financials, energy and industrial stocks initially suffered […]

Yahoo | December 15, 2021

Mednax Consensus Indicates Potential 14.9% Upside

Mednax with ticker code (MD) have now 10 analysts in total covering the stock. The consensus rating is ''Hold''. The target price ranges between 37 and 14 calculating the average target price we see 30.6. With the stocks previous close at 26.64 this would imply there is a potential upside of 14.9%. The 50 day moving average now sits at 26.97 while the 200 day moving average is 28.78. The market cap for the company is $2,324m. You can visit the company''s website by visiting: /> [stock_market_widget type="chart" symbol="MD" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] MEDNAX, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonata...

DirectorsTalk | December 9, 2021

First Bank & Trust Grows Position in MEDNAX, Inc. (NYSE:MD)

First Bank & Trust raised its position in MEDNAX, Inc. (NYSE:MD) by 12.1% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,192 shares of the companys stock after purchasing an additional 884 shares during the quarter. First Bank & []

Dakota Financial News | December 1, 2021

Bank of America Corp DE Has $7.47 Million Stock Position in MEDNAX, Inc. (NYSE:MD)

Bank of America Corp DE lessened its stake in shares of MEDNAX, Inc. (NYSE:MD) by 4.7% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 247,885 shares of the companys stock after selling 12,208 shares during the period. Bank of America Corp []

Transcript Daily | November 27, 2021

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8751 seconds.